Current Neuro-Oncology

Volume 27 Number 26
20 September 2025

Home > Publications > Current Neuro-Oncology > Volume 27, Year 2025 > Number 26, 20 September

Bota DA, Piccioni DE, Duma CM, Kesari S, Carrillo JA, LaRocca RV, Aiken RD, Taylor TH, Abedi M, Robles RM, Godding K, Keirstead HS, Nistor GI, Dillman RO.
Phase 2 trial of personal dendritic cell vaccines in newly diagnosed glioblastoma: 3-year follow-up and correlations with survival.
Hum Vaccin Immunother. 2025 Sep 12;21(1):2556591. doi: 10.1080/21645515.2025.2556591. PMID: 40938661. Interventional study. ˍ

Misztela-Lisiecka E, Waska G, Strozak A, Miernik-Skrzypczak MA, Nowakowski P.
From Tachycardia to Brain Tumor: An Unusual Evolution of Epilepsy.
Cureus. 2025 Sep 12;17(9):e92152. doi: 10.7759/cureus.92152. PMID: 41084664. Case report. ˍ

Akcil EF, Dilmen OK, Tunali Y.
Hypertonic saline versus mannitol for brain relaxation in supratentorial tumor surgery: a prospective randomized trial.
Braz J Anesthesiol. 2025 Sep 16;75(6):844684. doi: 10.1016/j.bjane.2025.844684. PMID: 40967382. Interventional study. ˍ

Rapp M, Fischer H, Steinmann J, Sabel M, Staub-Bartelt F.
Evaluation of Clinical Outcome and Survival Under Application of Various Therapies at First Recurrence in Patients with Glioblastoma.
J Clin Med. 2025 Sep 17;14(18):6550. doi: 10.3390/jcm14186550. PMID: 41010757. Observational study. ˍ

Uchimura M, Araki A, Eda H, Kimura Y, Hayashi K.
Diffuse midline glioma, H3K27-altered: a rare presentation with gliomatosis cerebri growth pattern and progression toward midline.
Brain Tumor Pathol. 2025 Sep 17. doi: 10.1007/s10014-025-00515-1. PMID: 40960709. Case report˰ ˍ

Alizada S, Aly Y, Bao H, Lakhani D, Yedavalli V, Sair H, Mei J.
Differentiation between Nonenhancing Tumor in Glioblastoma and Vasogenic Edema using Diffusion-Weighted and Dynamic Susceptibility Contrast MR Imaging.
AJNR Am J Neuroradiol. 2025 Sep 18. doi: 10.3174/ajnr.A8788. PMID: 40968014. Observational study˰ ˍ

Falcón A, Ponce S, Cote GM, Gil A, Lin JJ, Bockorny B, Martínez J, Kahatt C, Martinez S, Zubiaur P, Siguero M, Cullell-Young M, Jiménez J, Zugazagoitia J, Paz-Ares L.
Phase I results on the efficacy, safety and pharmacokinetics of lurbinectedin and irinotecan in advanced solid tumors.
Invest New Drugs. 2025 Sep 18. doi: 10.1007/s10637-025-01583-y. PMID: 40963055. Interventional study. ˍ

Toussaint L, Lind Helligsø AS, Muren LP, Amidi A, Hedegaard Dahlrot R, Tram Henriksen L, Vestmø Maraldo M, Skovmos Nielsen M, Trip AK, Wu LM, Lassen-Ramshad Y.
Impact of radiation dose on neurocognitive function and quality of life in long-term survivors of childhood brain tumour.
Acta Oncol. 2025 Sep 18;64:1245-1252. doi: 10.2340/1651-226X.2025.43989. PMID: 40965328. Observational study. ˍ

Wen J, Zhang Z, Zhao Y, Liu Y, Yuan J, Wang Y, Li J.
The Prognostic Value of a Nomogram Model Based on Tumor Immune Markers and Clinical Factors for Adult Primary Glioma.
Cancers (Basel). 2025 Sep 18;17(18):3043. doi: 10.3390/cancers17183043. PMID: 41008886. Observational study. ˍ

Duffau H.
Long-Term Outcomes in Patients With Isocitrate Dehydrogenase-Mutated Grade 2 Glioma Who Never Received Adjuvant Oncological Treatment After Upfront Mapping-Based Surgical Resection.
Neurosurgery. 2025 Sep 19. doi: 10.1227/neu.0000000000003760. PMID: 40970733. Observational study˰ ˍ

Ijare OB, Baskin DS, Powell SZ, Pichumani K.
Case Report: Metabolic alterations and cholesterol esterification in a low-grade diffuse astrocytoma patient who progressed to glioblastoma at recurrence.
Front Oncol. 2025 Sep 19;15:1651974. doi: 10.3389/fonc.2025.1651974. PMID: 41049838. Case report. ˍ

Parker A, Horsley P, Wheeler H, Venkatesha V, Kastelan M, Liu B, Back M.
Elderly Patients With Glioblastoma and Good Prognostic Factors May Achieve Equivalent Median Survival to Younger Patients When Managed With Standard Long-Course Rather Than Elderly Protocols.
J Med Imaging Radiat Oncol. 2025 Sep 19. doi: 10.1111/1754-9485.70020. PMID: 40971171. Observational study˰ ˍ

Cacchione A, Del Baldo G, D'Antonio F, Di Ruscio V, Megaro G, Pilotto C, Tornesello A, Cocciolo A, Vennarini S, Chiesa S, Carai A, De Salvo A, Albino G, Colafati GS, Slavc I, Mastronuzzi A.
Real-life experience with a "modified-MEMMAT" regimen for relapsed medulloblastoma.
Ther Adv Med Oncol. 2025 Sep 20;17:17588359251344002. doi: 10.1177/17588359251344002. PMID: 40985040. Observational study. ˍ